Time to Clearance of Chlamydia Trachomatis & Neisseria Gonorrhoeae RNA

See also
Status	Clinical Trial	Phase
Completed	`NCT03676816` - Self Sampling for Rapid Turnaround Testing in the Emergency Department	N/A
Completed	`NCT00213018` - Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission	Phase 2
Completed	`NCT00827970` - Randomized Population-Based Study on Chlamydia Trachomatis Screening	N/A
Completed	`NCT01733069` - Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System	N/A
Withdrawn	`NCT01358799` - Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System	N/A
Completed	`NCT00978848` - Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing	N/A
Completed	`NCT02391233` - Multimedia WORTH With Black Drug-Involved Women on Probation	N/A
Completed	`NCT00973466` - Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients	N/A
Completed	`NCT03071510` - Evaluation of the Atlas Genetics io® CTNG System
Recruiting	`NCT04446611` - Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes	N/A
Completed	`NCT01329588` - Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers	Phase 4
Terminated	`NCT02795975` - Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples	N/A
Completed	`NCT00213057` - Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand	Phase 1
Completed	`NCT00207454` - Optimizing Strategies to Improve STD Partner Services	Phase 1
Completed	`NCT00177437` - Home Screening for Chlamydia Surveillance	Phase 3
Completed	`NCT02787109` - Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years	Phase 1
Completed	`NCT01665690` - Washington State Community Expedited Partner Treatment (EPT) Trial	Phase 4
Completed	`NCT02128620` - A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour	N/A
Completed	`NCT00618449` - Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger	Phase 4
Recruiting	`NCT01661985` - Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced	Phase 4

NCT number	NCT06216964
Study type	Interventional
Source	University Hospital, Strasbourg, France
Contact	Axel Ursenbach, MD
Phone	0033.88.15.13.52
Email	axel.ursenbach@chru-strasbourg.fr
Status	Not yet recruiting
Phase	N/A
Start date	March 1, 2024
Completion date	November 1, 2025

Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study — DECHLAGO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms